An integrated microfluidic system for fast, automatic detection of C-reactive protein

• Published in: Sensors and actuators. B, Chemical Chemical, 2011-10, Vol.157 (2), p.710-721
• Main Authors: Lee, Wen-Bin, Chen, Yin-He, Lin, Hsin-I, Shiesh, Shu-Chu, Lee, Gwo-Bin
• Format: Article
• Language: English
• Subjects: air; Aptamer; automatic detection; blood; C-reactive protein; chemiluminescence; detection limit; DNA; humans; inflammation; Micro-injector; Microfluidics; Micropump; oligonucleotides; transportation; washing
• ISSN: 0925-4005; 1873-3077
• DOI: 10.1016/j.snb.2011.04.087

C-reactive protein (CRP) is a well-known inflammation marker in human beings. This study reports a new microfluidic system for fast, automatic detection of CRP. It contains pneumatic micropumps, a vortex-type micromixer, a pneumatic micro-injector and several microvalves to automatically perform the entire protocol for CRP detection. This includes sample/reagent transportation, incubation between the target CRP and a CRP-specific aptamer, washing processes, and the chemiluminescence development process. In addition, the chemiluminescence signal is measured by using a custom-made optical system which consists of a photomultiplier tube, a portable air compressor and eight electronic magnet valves to quantify the concentration of CRP. When compared to previous works, not only can this new microfluidic system automatically perform the entire process via a new integrated micro-injector and new micropumps, but a new CRP-specific DNA aptamer with a higher affinity and specificity is also used for CRP measurement. Experimental data show that the developed system can automatically complete the entire protocol within 30 min with a detection limit of 0.0125 mg/L, which is superior to previous published results. Moreover, this study also measures CRP concentration from clinical samples to verify the performance of the developed microfluidic system. The results indicate that the measured CRP concentrations from human serums are consistent with those using a benchtop system. The developed system can also detect CRP concentrations from human whole blood without any external sample pretreatment process. This microfluidic system may be promising for point-of-care applications for CRP detection in the future.